Clinical Trials Browser

Not yet recruiting × OTHER × Hydroxychloroquine × Clear all

NCT07061717 2025-07-11

Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer

Phase 3 Not yet recruiting

Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer